Skip to main content
. 2021 Jul 9;10(4):294–304. doi: 10.4103/EUS-D-20-00232

Table 5.

Clinical outcomes and adverse events (n=57)

Total (n=57) EUS-HGS (n=49) EUS-HJS (n=8) P
Clinical success rate 91.2% (52/57) 89.85% (44/49) 100% (8/8) 0.353
Adverse events rate 15.7% (9/57) 18.45% (9/49) 0% (0/8) 0.193
 Peritonitis (bile juice leakage) 4 4 0
 Bleeding 2 2 0
 Cholecystitis 2 2 0
 Pneumoperitoneum 1 1 0
Stent migration 0% (0/57) 0% (0/49) 0% (0/8) NA

HGS: Hepaticogastrostomy; HJS: Hepaticojejnostomy; NA: Not available